XML 69 R54.htm IDEA: XBRL DOCUMENT

Parent Corporation Only Financial Statements (Tables)

12 Months Ended

Dec. 31, 2017

Condensed Financial Information of Parent Company Only Disclosure [Abstract]

Condensed Balance Sheet [Table Text Block]

Condensed financial statements of the Parent Corporation only are as follows:

Condensed Statements of Condition

		At December 31,
		2017				2016
		(dollars in thousands)
ASSETS
Cash and cash equivalents		$	7,506			$	7,008
Investment in subsidiaries			614,083				580,048
Securities available-for-sale			779				730
Other assets			322				426
Total assets		$	622,690			$	588,212
LIABILITIES AND STOCKHOLDERS’ EQUITY
Other liabilities		$	2,554			$	2,646
Subordinated debentures			54,699				54,534
Stockholders’ equity			565,437				531,032
Total liabilities and stockholders’ equity		$	622,690			$	588,212

Condensed Income Statement [Table Text Block]

Condensed Statements of Income

		For Years Ended December 31,
		2017				2016				2015
		(dollars in thousands)
Income:
Dividend income from subsidiaries		$	13,000			$	12,400			$	10,537
Other income			13				8				7
Total Income			13,013				12,408				10,544
Expenses			(3,251)				(3,252)				(1,705)
Income before equity in undistributed earnings of subsidiaries			9,762				9,156				8,839
Equity in undistributed earnings of subsidiaries			33,458				21,926				32,472
Net Income		$	43,220			$	31,082			$	41,311

Condensed Cash Flow Statement [Table Text Block]

Condensed Statements of Cash Flows

		For Years Ended December 31
		2017				2016				2015
		(dollars in thousands)
Cash flows from operating activities:
Net income		$	43,220			$	31,082			$	41,311
Adjustments to reconcile net income to net cash provided by operating activities:
Equity in undistributed earnings of subsidiary			(33,458)				(21,926)				(32,472)
Increase in other assets			269				2,023				(820)
Increase (decrease) in other liabilities			(151)				544				(752)
Net cash provided by operating activities			9,880				11,723				7,267

Cash flows from investing activities:
Purchase of available-for-sale securities			(7)				-				-
Capital infusion to subsidiary			-				(38,439)				(35,000)
Net cash used in investing activities			(7)				(38,439)				(35,000)

Cash flows from financing activities:
Proceeds from subordinated debt			-				-				50,000
Cash dividends on common stock			(9,612)				(9,067)				(8,996)
Cash dividends on preferred stock			-				(22)				(112)
Issuance cost of common stock			(180)								-
Secondary offering of common stock			-				38,439				-
Redemption of preferred stock			-				(11,250)				-
Proceeds from exercise of stock options			417				767				1,424
Net cash used in financing activities			(9,375)				18,867				42,316

Decrease in cash and cash equivalents			498				(7,849)				14,583
Cash and cash equivalents at January 1,			7,008				14,857				274
Cash and cash equivalents at December 31,		$	7,506			$	7,008			$	14,857